🔗 Permalink

Inventor profile of:

Patrick Andre

City:

San Mateo, California

Country:

United States

Published Applications:

Last publication date:

2024-03-14

Top Assignees for applications by Patrick Andre

The entities that hold a legal rights for patent applications filed by inventor Andre Patrick:

Portola Pharmaceuticals, Inc. 13 South San Francisco, CA United States
Portola Pharmaceuticals, Inc. 4 So. San Francisco, CA United States
Millennium Pharmaceuticals, Inc. 2 Cambridge, MA United States
Portola Phamaceuticals, Inc. 1 So. San Francisco, CA United States
CBR, Inc. 1 Boston, MA United States
CBR Institute for Biomedical Research 1 Boston, MA United States
ALEXION PHARMACEUTICALS, INC. 1 Boston, MA United States
Millenium Pharmaceuticals, Inc. 1 Cambridge, MA United States

Recent patent applications by Andre Patrick

Patrick Andre from San Mateo, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-03-14

US20240082367A1

Human necessities

ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME

#2 | 2020-09-03

US20200276280A1

Human necessities

Antidotes for factor Xa inhibitors and methods of using the same

#3 | 2016-12-08

US20160354449A1

Human necessities

Antidotes for factor Xa inhibitors and methods of using the same

#4 | 2015-02-26

US20150057228A1

Chemistry; metallurgy

Antidotes for factor Xa inhibitors and methods of using the same

#5 | 2014-03-20

US20140079684A1

Chemistry; metallurgy

Antidotes for factor Xa inhibitors and methods of using the same

#6 | 2014-02-13

US20140044773A1

Chemistry; metallurgy

Antidotes for factor XA inhibitors and methods of using the same

#7 | 2013-11-28

US20130315897A1

Human necessities

Combination Anticoagulant Therapy With A Compound That Acts As A Factor Xa Inhibitor

#8 | 2012-10-25

US20120269788A1

Human necessities

Antidotes for factor Xa inhibitors and methods of using the same

#9 | 2012-02-23

US20120046230A1

Human necessities

Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor

#10 | 2012-02-02

US20120027834A1

Human necessities

Methods of treatment with Syk inhibitors

#11 | 2012-01-12

US20120009172A1

Human necessities

INTRAVENOUS AND ORAL DOSING OF A DIRECT-ACTING AND REVERSIBLE P2Y12 INHIBITOR

#12 | 2011-02-10

US20110033459A1

Human necessities

Combination therapy with a compound acting as a platelet ADP receptor inhibitor

#13 | 2009-04-16

US20090098119A1

Human necessities

Antidotes for factor Xa inhibitors and methods of using the same

#14 | 2009-02-19

US20090048216A1

Human necessities

INTRAVENOUS AND ORAL DOSING OF A DIRECT-ACTING AND REVERSIBLE P2Y12 INHIBITOR

#15 | 2009-01-08

US20090012136A1

Human necessities

UNIT DOSE FORMULATIONS AND METHODS OF TREATING AND PREVENTING THROMBOSIS WITH THROMBOXANE RECEPTOR ANTAGONISTS

#16 | 2009-01-08

US20090012115A1

Human necessities

USE OF TP MODULATORS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS IN ASPIRIN SENSITIVE AND OTHER POPULATIONS

#17 | 2008-11-13

US20080279845A1

Human necessities

COMBINATION THERAPY WITH A COMPOUND ACTING AS A PLATELET ADP RECEPTOR INHIBITOR

#18 | 2008-10-16

US20080254036A1

Human necessities

COMBINATION ANTICOAGULANT THERAPY WITH A COMPOUND THAT ACTS AS A FACTOR XA INHIBITOR

#19 | 2008-08-28

US20080207681A1

Physics

Device and methods for identifying and treating aspirin non-responsive patients

#20 | 2007-09-18

US10476237

Compounds and methods for the modulation of CD154

#21 | 2006-09-21

US20060211071A1

Physics

Device for aggregating, imaging and analyzing thrombi and a method of use

#22 | 2006-07-20

US20060160165A1

Physics

Device and methods for identifying and treating aspirin non-responsive patients

#23 | 2005-10-20

US20050232969A1

Human necessities

Methods of treatment with Syk inhibitors

#24 | 2005-03-01

US10002585

Compounds and methods for the modulation of CD154

InventorID:

547175 ⎘